Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even if President Donald Trump imposes high tariffs because they are "highly ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
(Reuters) - Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results